SCOZZAFAVA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 42.557
EU - Europa 14.553
AS - Asia 3.213
AF - Africa 217
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 9
OC - Oceania 8
Totale 60.573
Nazione #
US - Stati Uniti d'America 42.475
RU - Federazione Russa 4.529
SE - Svezia 2.230
PL - Polonia 2.229
IE - Irlanda 1.964
IT - Italia 1.233
SG - Singapore 1.054
HK - Hong Kong 887
FI - Finlandia 646
DE - Germania 606
UA - Ucraina 456
GB - Regno Unito 431
IN - India 423
TR - Turchia 373
CN - Cina 224
CI - Costa d'Avorio 198
JO - Giordania 113
CA - Canada 82
VN - Vietnam 80
CH - Svizzera 49
BE - Belgio 43
KR - Corea 43
FR - Francia 38
NL - Olanda 36
ES - Italia 28
EU - Europa 16
SC - Seychelles 14
AT - Austria 9
RO - Romania 7
BG - Bulgaria 6
BR - Brasile 6
JP - Giappone 6
LT - Lituania 6
NZ - Nuova Zelanda 5
IR - Iran 4
AU - Australia 3
DK - Danimarca 3
AR - Argentina 2
CZ - Repubblica Ceca 2
MU - Mauritius 2
TW - Taiwan 2
AZ - Azerbaigian 1
BY - Bielorussia 1
CO - Colombia 1
EG - Egitto 1
GR - Grecia 1
ID - Indonesia 1
NG - Nigeria 1
PK - Pakistan 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 60.573
Città #
Fairfield 7.911
Santa Clara 4.096
Woodbridge 3.616
Seattle 3.265
Ashburn 3.188
Cambridge 3.075
Houston 2.826
Wilmington 2.509
Warsaw 2.224
Chandler 2.076
Dublin 1.962
Jacksonville 1.161
Ann Arbor 1.067
Lawrence 863
Singapore 814
Altamura 733
Princeton 639
Boardman 483
Medford 396
Boston 333
Izmir 301
San Diego 301
Mumbai 273
Abidjan 198
Hong Kong 187
Florence 145
Norwalk 126
Moscow 122
Beijing 83
Falls Church 77
Buffalo 71
Andover 70
Hillsboro 65
Dong Ket 64
Dearborn 62
Toronto 60
Bern 48
Shanghai 48
Los Angeles 45
Düsseldorf 44
Brussels 43
Milan 43
Helsinki 42
London 42
New York 42
Kent 36
Yubileyny 32
Auburn Hills 26
Barcelona 25
Tappahannock 23
Laurel 22
Phoenix 19
Redmond 16
Romola 16
Salerno 16
Frankfurt Am Main 15
Chiswick 14
West Jordan 14
Kilburn 12
Bremen 11
Grevenbroich 11
Redwood City 11
San Mateo 11
Prescot 10
Verona 10
Hounslow 9
Rome 9
Vienna 9
Gavirate 8
Old Bridge 8
Seoul 8
Detroit 7
Seongnam 7
Yaroslavl 7
Leawood 6
Montréal 6
Napoli 6
New Bedfont 6
Scandicci 6
Siena 6
Timisoara 6
Trumbull 6
Washington 6
Arnsberg 5
Chicago 5
Incisa 5
Naaldwijk 5
Sofia 5
Southwark 5
Abbotsford 4
Ardea 4
Bari 4
Fort Worth 4
Guangzhou 4
Jinan 4
Naples 4
Ottawa 4
Saint-Fons 4
Serra 4
Venice 4
Totale 46.389
Nome #
A 31P NMR study of phosphate in presence of cobalt(II)- and copper(II)- substituted bovine carbonic anhydrase B. 316
Biotransformation of Chloroaromatics: the Impact of Bioavailability and Substrate Specificity. 289
Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors. 273
Glycosyl Coumarin Carbonic Anhydrase IX and XII Inhibitors Strongly Attenuate the Growth of Primary Breast Tumors. 263
Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. 258
Characterization of the first beta-class carbonic anhydrase from an arthropod (Drosophila melanogaster) and phylogenetic analysis of beta-class carbonic anhydrases in invertebrates. 258
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis 245
Carbonic anhydrase inhibitor coated gold nanoparticles selectively inhibit the tumor-associated isoform IX over the cytosolic isozymes I and II. 243
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis 240
Assembly comprising an absorber of near infrared (nir) light covalently linked to an inhibitor of carbonic anhydrase 240
Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations. 235
Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. 227
Carbonic Anhydrase Activators: Gold Nanoparticles Coated with Derivatized Histamine, Histidine, and Carnosine Show Enhanced Activatory Effects on Several Mammalian Isoforms. 225
Crystal structure of a blue laccase from Lentinus tigrinus: evidences for intermediates in the molecular oxygen reductive splitting by multicopper oxidases. 216
Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. 210
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? 189
Biodegradation of 2-naphthalensulfonic acid polymers by white-rot fungi: Scale-up into non-sterile packed bed bioreactors 181
Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase 177
Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors 169
Next-generation polyamine human carbonic anhydrase inhibitors 163
Structural effect of phenyl ring compared to thiadiazole based adamantyl-sulfonamides on carbonic anhydrase inhibition 163
Structural modulation of the biological activity of gold nanoparticles functionalized with a carbonic anhydrase inhibitor. 159
1,3-Oxazole-based selective picomolar inhibitors of cytosolic human carbonic anhydrase II alleviate ocular hypertension in rabbits: Potency is supported by X-ray crystallography of two leads 154
3D QSAR selectivity analyses of carbonic anhydrase inhibitors: insights for the design of isozyme selective inhibitors. 151
Complexes With Biologically Active Ligands. Part 6 Ni(II) Coordination Compounds of Hydrazine and Heterocyclic Sulfonamides as Inhibitors of the Zinc Enzyme Carbonic Anhydrase. 150
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense. 148
Carbonic anhydrase activators: X-ray crystallographic and spectroscopic investigations for the interaction of isozymes I and II with histamine. 147
Combined action of a bacterial monooxygenase and a fungal laccase for the biodegradation of mono- and poly-aromatic hydrocarbons. 146
Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. 144
Characterization of the biological conversion of naphthalene to (+)-cis-(1R,2S)-dihydroxy-1,2-dihydronaphthalene in direct micellar systems 142
Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. 141
7-Substituted-sulfocoumarins are isoform-selective, potent carbonic anhydrase II inhibitors. 141
Antiglaucoma carbonic anhydrase inhibitors: a patent review. 141
7,8-disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar/subnanomolar range. 139
Cyclodextrin complexation highly enhances efficacy of arylsulfonylureido benzenesulfonamide carbonic anhydrase inhibitors as a topical antiglaucoma agents 139
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis 139
Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA. 138
Unsymmetrical 1,1'-disubstituted ferrocenes: synthesis of Co(ii), Cu(ii), Ni(ii) and Zn(ii) chelates of ferrocenyl -1-thiadiazolo-1'-tetrazole, -1-thiadiazolo-1'-triazole and -1-tetrazolo-1'-triazole with antimicrobial properties. 138
Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. 138
Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray crystal structure of the antiviral drug foscarnet complexed to human carbonic anhydrase I. 138
Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions. 137
A class of 4-Sulfamoylphenyl-ω-aminoalkyl ethers with effective carbonic anhydrase inhibitory action and antiglaucoma effects. 136
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. 136
Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. 136
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. 135
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. 135
Antiobesity carbonic anhydrase inhibitors: a literature and patent review. 135
Efficient polycyclic aromatic hydrocarbons dihydroxylation in direct micellar systems 134
Carbonic anhydrase inhibitors. Part 91. Metal complexes of heterocyclic sulfonamides as potential pharmacological agents in the treatment of gastric Acid secretion imbalances. 134
Plasmonic Particles that Hit Hypoxic Cells 134
Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. 134
5- and 6-membered (thio)lactones are prodrug type carbonic anhydrase inhibitors. 133
Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates. 133
Carbonic anhydrase inhibitors: guaiacol and catechol derivatives effectively inhibit certain human carbonic anhydrase isoenzymes (hCA I, II, IX and XII). 133
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. 133
Salicylate 1,2-dioxygenase from Pseudaminobacter salicylatoxidans: crystal structure of a peculiar ring-cleaving dioxygenase. 133
ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme 133
Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. 133
Carbonic Anhydrase Inhibitors. Part 55 Metal Complexes of 1,3,4-Thiadiazole-2-Sulfonamide Derivatives: In Vitro Inhibition Studies With Carbonic Anhydrase Isozymes I, II and IV. 132
Crystal structure of the blue multicopper oxidase from the white-rot fungus Trametes trogii complexed with p-toluate 131
6-Substituted 1,2-benzoxathiine-2,2-dioxides are isoform-selective inhibitors of human carbonic anhydrases IX, XII and VA. 131
Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. 131
Carbonic anhydrase inhibitors: Design of spin-labeled sulfonamides incorporating TEMPO moieties as probes for cytosolic or transmembrane isozymes 131
Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. 130
Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action 130
Carbonic Anhydrase Activators. Part 19 Spectroscopic and Kinetic Investigations for the Interaction of Isozymes I and II With Primary Amines. 129
Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. 129
Carbonic anhydrase inhibitors. Inhibition of isoforms I, II, IV, VA, VII, IX, and XIV with sulfonamides incorporating fructopyranose-thioureido tails. 129
Pyridinium derivatives of histamine are potent activators of cytosolic carbonic anhydrase isoforms I, II and VII. 129
Polyamines and α-carbonic anhydrases 129
Peptidomimetics as protein arginine deiminase 4 (PAD4) inhibitors. 129
Crystallization and preliminary structure analysis of the blue laccase from the ligninolytic fungus Panus tigrinus. 129
Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides. 128
Secondary/tertiary benzenesulfonamides with inhibitory action against the cytosolic human carbonic anhydrase isoforms I and II. 128
Specific inhibition of carbonic anhydrase IX activity enhances the in vivo therapeutic effect of tumor irradiation. 127
Carbonic anhydrase inhibitors: inhibition studies of a coral secretory isoform with inorganic anions. 127
Role of surfactants in optimizing fluorene assimilation and intermediate formation by Rhodococcus rhodochrous VKM B-2469. 127
Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors. 127
H-1 Noe Studies Of Oxidized High-Potential Iron Sulfur Protein-II From Ectothiorhodospira-Halophila 126
Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors. 126
Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. 126
Complexes with biologically active ligands. Part 11. Synthesis and carbonic anhydrase inhibitory activity of metal complexes of 4,5-disubstituted-3-mercapto-1,2,4-triazole derivatives. 126
Carbonic anhydrase inhibitors. Biphenylsulfonamides with inhibitory action towards the transmembrane, tumor-associated isozymes IX possess cytotoxic activity against human colon, lung and breast cancer cell lines. 126
Carbonic anhydrase inhibitors: cloning, characterization, and inhibition studies of the cytosolic isozyme III with sulfonamides. 126
Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. 126
N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors. 126
Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines. 126
Carbonic anhydrase activators: X-ray crystal structure of the adduct of human isozyme II with L-histidine as a platform for the design of stronger activators. 126
Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. 126
Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma. 126
QSAR studies for the inhibition of the transmembrane carbonic anhydrase isozyme XIV with sulfonamides using PRECLAV software. 125
Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. 125
Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. 125
Investigations of the esterase, phosphatase, and sulfatase activities of the cytosolic mammalian carbonic anhydrase isoforms I, II, and XIII with 4-nitrophenyl esters as substrates. 125
Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations. 125
Combining the tail and the ring approaches for obtaining potent and isoform-selective carbonic anhydrase inhibitors: solution and X-ray crystallographic studies. 125
Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II and IX with some 1,3,4-oxadiazole- and 1,2,4-triazole-thiols. 125
Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII. 125
Carbonic anhydrase IX from cancer-associated fibroblasts drives epithelial-mesenchymal transition in prostate carcinoma cells 125
X-ray structures of 4-chlorocatechol 1,2-dioxygenase adducts with substituted catechols: New perspectives in the molecular basis of intradiol ring cleaving dioxygenases specificity. 125
Totale 15.275
Categoria #
all - tutte 155.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 155.606


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.929 0 0 0 0 1.763 1.947 1.822 1.942 1.701 725 711 318
2020/20216.853 732 566 619 395 231 864 203 597 682 782 554 628
2021/20224.241 247 446 502 116 169 182 234 256 164 178 623 1.124
2022/20239.115 1.103 1.841 135 674 846 1.739 865 642 801 39 276 154
2023/20242.255 157 401 623 157 141 272 46 264 27 39 71 57
2024/202511.392 711 2.092 1.265 2.380 4.944 0 0 0 0 0 0 0
Totale 60.711